Skip to main content

Advertisement

Figure 2 | Diabetology & Metabolic Syndrome

Figure 2

From: Improvement of both fasting and postprandial glycemic control by the two-step addition of miglitol and mitiglinide to basal insulin therapy: a pilot study

Figure 2

Median 7-point SMBG and CGM of all the patients at STEP0 and at the end of the treatment regimen. A. Median 7-point SMBG of all the patients at STEP 0 and at the end of the treatment regimen. Black line: all the patients at STEP 0, Gray line: all the patients at the end of the treatment regimen. BB: before breakfast, AB: after breakfast, BL: before lunch, AL: after lunch, BD: before dinner, AD: after dinner, BS: before sleep. *value of SMBG of all the patients at STEP 0 vs. those at the end of the treatment regimen P < 0.05. B. Median CGM of all the patients at STEP 0 and at the end of the treatment regimen. Black line: all the patients at STEP 0, Gray line: all the patients at the end of the treatment regimen.

Back to article page